Andros Pharmaceuticals (竟天生物科技股) is a biopharmaceutical company engaged in developing drug delivery platform technologies. It focuses on the development of new dosage form and non-viral gene delivery systems, with the current pipeline indicated for pain management, DNA repair, and gene therapy.